Monitoring cardiovascular health in men with prostate cancer treated with androgen deprivation therapy
Earlier diagnosis and improved treatments have resulted in men with prostate cancer living for many years following diagnosis. Long‐term effects of treatments are therefore important. Androgen deprivation therapy (ADT) is now commonly used to treat prostate cancer. We have estimated that, in Australia, 6500 men used ADT in 1999/2000 with a steady increase to about 21 800 men in 2009/2010 (over 300% increase), a trend similar to those in the USA and UK. ADT has a range of side‐effects that can impact on quality of life such that risks and...
Published By: MedWorm/Smoking - Wednesday, 22 February
- Older News
Vote! Long-Term Dynamics of Bone Mineral Density During Intermittent Androgen Deprivation for Men With Nonmetastatic, Hormone-Sensitive Prostate Cancer [Urologic Oncology] MedWorm/DeathRecovery (Yesterday) - Conclusion Patients experienced the greatest average change in BMD during early treatment periods of IAD...
Vote! U.S. Advisers Say 'No' to Routine PSA Tests for Prostate Cancer CancerCompass/Top (Yesterday) - Benefits of prostate-specific antigen screening don't outweigh harms, panel contends...